En développement
Business·09/07/2026Résumé IA
Novo Nordisk's Wegovy and Ozempic Gain Ground as Indian Generics Slow
Novo Nordisk's weight-loss drugs Wegovy and Ozempic are seeing steady sales growth in India, outpacing generic versions. This comes as the frenzy for Indian generics wanes amid a crowded market, with innovators maintaining a steadier growth trajectory.
E
Economic Times3 min de lecture